The largest database of trusted experimental protocols

9 protocols using anti ccr7

1

PBMC Isolation and Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated via standard density gradient centrifugation and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mm l‐glutamine, 100 μg mL−1 streptomycin and 100 U mL−1 penicillin (all from Life Technologies, San Diego, CA, USA). Freshly prepared cells for analysis in the absence of in vitro stimulation were either used directly in flow cytometric experiments or placed in culture overnight for concurrent analysis with stimulated cells. All antibody reagents, either purified or pre‐conjugated, were obtained from BD Biosciences (San Diego, CA, USA), except (1) anti‐TRAV10 (Vα24), anti‐TRBV25 (Vβ11) and anti‐CD127 (Beckman Coulter, Brea, CA, USA); (2) anti‐granzyme B (Caltag, Burlingame, CA, USA); and (iii) anti‐CCR7 (R&D Systems, Minneapolis, MN, USA). Multimeric complexes of PBS57‐hCD1d, a ligand analog of αGalCer‐CD1d, were obtained from the National Institutes of Health Tetramer Facility.
+ Open protocol
+ Expand
2

Multiparametric Phenotyping of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
To define the memory vs. naïve subsets, the following antibodies were used: SP34–2 (CD3; Alexa700, BD Biosciences), L200 (CD4; AmCyan, BD Bioscienes), SK-1 (CD8; PerCP-cy-5.5, BD Biosciences), MAB11 (TNFα; FITC, eBioscience), B27 (IFNγ; APC, BD Pharmingen), FN50 (CD69; PE, BD Biosciences), CD28.2 (CD28; PE-TexasRed, BD Biosciences), 150503 (CCR7; R&D Systems), and SA (PacBlue, BD Biosciences). CCR7 was biotinylated using the EZ-link Malemide-PEO Solid Phase Biotinylation kit from Fisher Scientific, as per manufacturer instructions. For cell recognition and T cell response assays, the following antibodies were used: anti-CD3 (clone: SP34–2, Pacific Blue; BD Biosciences), anti-CD8 (clone: SK1, TruRed; BD Biosciences), anti-CD4 (clone: L200, PE-Cy7, BV395; BD Biosciences), anti-CD28 (clone: CD28.2, PE; BD Biosciences), anti-CD95 (clone: DX2, FITC; BD Biosciences), anti-CD69 (clone: FN50, ECD, Biolegend), anti-CCR7 (clone: 150503, Pacific Blue, R&D Systems), anti-IFNγ (clone: B27, FITC; BD Biosciences), anti-TNFα (clone: MAb11, Alexa 700; BD Biosciences), and LIVE/DEAD Fixable Yellow Dead Cell Stain (Life Technologies) was used to assess cell viability.
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was done using the following monoclonal antibodies (mAb) and appropriate isotype controls: anti-HLA class I (W6/32), anti-HLA DR/DP (Q5/13), anti-HLA DR, anti-CD70, anti-CD80 (all BD Biosciences), anti-CD14, anti-CD83 (both Beckman Coulter), anti-CD86 (BD PharMingen), and anti-CCR7 (R&D systems). For intracellular staining of the TAA NKI/beteb (IgG2b; purified antibody) against gp100, and T311 (IgG2a; Cell Marque Corp., Rocklin, CA) against tyrosinase were used. Cells were also stained intracellular with anti-CD40L (Beckman Coulter). For intracellular staining, cells were fixed for 4′ on ice in 4% (w/v) paraformaldehyde (Merck) in PBS, permeabilized in PBS/2%BSA/0.02% azide/0.5% saponin (Sigma-Aldrich) (PBA/saponin), and stained with mAb diluted in PBA/saponin/2%HS, followed by staining with Alexa488-labeled goat-anti-mouse (BD PharMingen). Flow cytometry was performed with FACSCalibur™ flow cytometer equipped with CellQuest software (BD Biosciences).
+ Open protocol
+ Expand
4

Transwell Migration of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Migration of T cells was assessed by using transwell permeable supports with 5-μm polycarbonate membrane (Costar, 3387). To determine cell migration in response to soluble factors, the lower chamber was loaded with 0.1% FBS, 200 ng/ml CCL21 (Peprotech, 250-13), 200 ng/ml CCL19 (Peprotech, 250-27B), 150 ng/ml CXCL9 (Peprotech 250-18) or 50 ng/ml CXCL10 (Peprotech, 250-16) in T-cell medium. T cells were incubated for 2 (naïve) or 3 hours (activated) at 37°C and migrated cells in the bottom chamber were collected and counted by flow cytometry using Precision Count Beads™. According to the experimental requirements, activated T cells were pre-treated for 1 hour with 10 μg/ml anti-CCR7 (R&D, 4B12), 250 μg/ml anti-CXCR3 (Biolegend, CXCR3-173), 100 μM Rac1 inhibitor NSC23766 or the appropriate isotype or vehicle control.
+ Open protocol
+ Expand
5

Investigating Protein Interactions and Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in the RIPA buffer (Beyotime) containing 1% Protease/Phosphatase Inhibitor Cocktail (MCE) and PMSF. The BCA Protein Assay Kit (Epizyme) was applied to measure protein concentrations. Western blot analysis was carried out as previously described.22 For coimmunoprecipitation assays, MIA‐PaCa‐2 and SW1990 cells were transfected with the indicated plasmids according to manual of Lipofectamine 3000’s manufacturer (Sigma‐Aldrich). Immunoprecipitation was undertaken as described previously.22, 23 In this study, anti‐PD‐L1 (ab228415) was purchased from Abcam. Anti‐phospho‐AKT (Ser473)(9271), anti‐AKT (9272), anti‐phospho‐GSK‐3β (ser9)(9323), anti‐GSK‐3β (12456), anti‐GAPDH (5174), and anti‐β‐actin (4970) were purchased from Cell Signaling Technology. Anti‐Ccl21 (AF457‐SP) and anti‐CCR7 (150503) were purchased from R&D Systems.
+ Open protocol
+ Expand
6

Comprehensive Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated with fluorochrome-conjugated mAbs and analyzed on either an FC 500 (Beckman Coulter) or an LSRFortessa (Becton Dickinson) flow cytometer. FITC-, PE-, PE-Texas Red-, ECD-, APC-, PE-Cy5–, PE-Cy7–, PerCP-Cy5.5–, Pacific Blue-, and AF700-conjugated mouse anti-human mAbs included anti-CD3, anti-CD4, anti-CD8, anti-CD11c, anti-CD14, anti-CD16 (clone 3G8), anti-CD19, anti-CD25, ant-CD28, anti-CD45RA, anti-CD45RO, anti-CD80, anti-CD86, anti-CD123, anti-CTLA-4, anti–HLA-DR, anti-IL2, anti-Ki-67 (BD Pharmingen), anti-CD56, anti-CD83 (Beckman Coulter), anti-CD127, anti- IFNγ, anti-LAG-3, anti-PD-1, anti- TNFα (eBioscience), anti-CCR7, anti-TIM-3 (R&D Systems), and anti-CD57 (BioLegend). Nonreactive isotype-matched antibodies (Becton Dickinson, eBioscience, R&D Systems) were used as controls. LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Life Technologies) facilitated exclusion of dead cells. Gates were set for collection and analysis of at least 20,000 live events. Data were analyzed with FlowJo 9.5 software (TreeStar).
+ Open protocol
+ Expand
7

Phenotypic Analysis of Virus-Specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells from blood, spleen and tonsils were stained with fluorochrome-conjugated antibodies (mAbs) specific for cell surface proteins. The following mAbs were used for identification of CD8+ T cells and the determination of their phenotype; anti-CD3, anti-CD8 (Biolegend), anti-CCR7 (R&D Systems), anti-CD45RA (BD Biosciences), anti-CD69, anti-CD25, anti-CD137, anti-HLA-DR, anti-CD103, anti-KLRG-1 and anti-CD11a (all obtained from Biolegend). Fluorochrome-conjugated HLA class I dextramers (Immudex) were used to identify virus-specific CD8+ T cells. EBV-specific CD8+ T cells were identified with dextramers specific for the following viral epitopes; GLCTLVAML (derived from EBV-lytic protein BMLF1), CLGGLLTMV (derived from EBV-latent protein LMP2), RAKFKQLL (derived from EBV-lytic protein BZLF1) and FLRGRAYGL (derived from EBV-latent protein EBNA3A). CMV-specific CD8+ T cells were identified with dextramers specific for the following viral epitopes; NLVPMVATV, TPRVTGGGAM, RPHERNGFTV (all derived from pp65 protein), VLEETSVML, ELRRKMMYM, ELKRKMMYM (all derived from IE-1 protein) and VTEHDTLLY (derived from pp50 protein). Stained cells were analyzed on either FACSCanto II or LSRFortessa flow cytometer (BD Biosciences) and the data processed using FlowJo software (Treestar, Ashland, USA).
+ Open protocol
+ Expand
8

Comprehensive Lymphocyte Subset Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The leukapheresis products were suspended in RPMI 1640 medium (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal calf serum and were analyzed using flow cytometry. Eight-colour analyses were performed for the identification of the lymphocyte subsets with the following monoclonal antibodies: CD2, CD3, CD4, CD5, CD7, CD16, CD25, CD56, CD45, CD45RA, CD45RO, CD9, CD127, CCR7, and HLA-DR antigens. All antibodies were purchased from BD Biosciences (San José, CA, USA) except for anti-CD8, anti-CD56, and anti-CD127 which were purchased from Beckman Coulter (Brea, CA, USA); anti-CCR7 was purchased from R&D systems (MN, USA) and anti HLA-DR from Biolegend (San Diego, CA, USA). The Blood Dendritic Cell Enumeration Kit (Miltenyi Biotech GmbH, Bergish Gladbach, Germany) was used according to the supplier's protocol to determine plasmacytoid dendritic cells, type 1 and type 2 myeloid dendritic cells. Flow cytometry analysis was performed on the LSR II instrument (BD Biosciences). Data analysis was performed using the Flow-Jo software (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand
9

Transwell Assay for T Cell Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Migration of T cells was assessed by using Transwell permeable supports with 5-μm polycarbonate membrane (Costar, 3387). To determine cell migration in response to soluble factors, the bottom chamber was loaded with 0.1% FBS, 200 ng/mL CCL21 (PeproTech, 250–13), 200 ng/mL CCL19 (PeproTech, 250–27B), 150 ng/mL CXCL9 (PeproTech 250–18), or 50 ng/mL CXCL10 (PeproTech, 250–16) in T-cell medium. T cells were incubated for 2 (naïve) or 3 hours (activated) at 37°C and migrated cells in the bottom chamber were collected and counted by flow cytometry using Precision Count Beads. According to the experimental requirements, activated T cells were pretreated for 1 hour with 10 μg/mL anti-CCR7 (R&D Systems, 4B12), 250 μg/mL anti-CXCR3 (BioLegend, CXCR3–173), 100 μmol/L Rac1 inhibitor NSC23766, or the appropriate isotype, or vehicle control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!